These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23804383)

  • 1. Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine.
    Ntziora F; Paraskevis D; Haida C; Manesis E; Papatheodoridis G; Manolakopoulos S; Elefsiniotis I; Karamitros T; Vassilakis A; Hatzakis A
    J Clin Microbiol; 2013 Sep; 51(9):2893-900. PubMed ID: 23804383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology.
    Ntziora F; Paraskevis D; Haida C; Magiorkinis E; Manesis E; Papatheodoridis G; Manolakopoulos S; Beloukas A; Chryssoy S; Magiorkinis G; Sypsa V; Hatzakis A
    J Clin Microbiol; 2009 Aug; 47(8):2544-50. PubMed ID: 19553583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of LigAmp assay for sensitive detection of drug-resistant hepatitis B virus minor variants in comparison with standard nucleotide sequencing.
    Ismail AM; Sachithanandham J; Eapen CE; Kannangai R; Abraham P
    Mol Diagn Ther; 2014 Dec; 18(6):655-63. PubMed ID: 25208639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.
    Liu Y; Wang C; Zhong Y; Li X; Dai J; Ren X; Xu Z; Li L; Yao Z; Ji D; Wang L; Zhang L; Wong VW; Zoulim F; Xu D
    J Viral Hepat; 2011 Apr; 18(4):e29-39. PubMed ID: 21392168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.
    Zeng Y; Li D; Wang W; Su M; Lin J; Chen H; Jiang L; Chen J; Yang B; Ou Q
    PLoS One; 2014; 9(2):e90029. PubMed ID: 24587198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B.
    Zeng Y; Yang B; Wu Y; Chen J; Shang H; Chen X; Su M; Wu S; Lin J; Ou Q
    J Med Microbiol; 2015 Mar; 64(Pt 3):237-242. PubMed ID: 25596114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].
    Liang PP; Guo JJ; Li QL; Luo Q; Shi XF; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):516-20. PubMed ID: 22152243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.
    Singla B; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
    J Med Virol; 2013 Jul; 85(7):1155-62. PubMed ID: 23918533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
    Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
    Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.
    Choe WH; Kim K; Lee SY; Choi YM; Kwon SY; Kim JH; Kim BJ
    World J Gastroenterol; 2019 Sep; 25(33):4985-4998. PubMed ID: 31543688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Anti-Hepatitis B Virus Drug Resistance Mutations Based on Multicolor Melting Curve Analysis.
    Mou Y; Athar MA; Wu Y; Xu Y; Wu J; Xu Z; Hayder Z; Khan S; Idrees M; Nasir MI; Liao Y; Li Q
    J Clin Microbiol; 2016 Nov; 54(11):2661-2668. PubMed ID: 27535686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
    Gomes-Gouvêa MS; Ferreira AC; Teixeira R; Andrade JR; Ferreira AS; Barros LM; Rezende RE; Nastri AC; Leite AG; Piccoli LZ; Galvan J; Conde SR; Soares MC; Kliemann DA; Bertolini DA; Kunyoshi AS; Lyra AC; Oikawa MK; de Araújo LV; Carrilho FJ; Mendes-Corrêa MC; Pinho JR
    Antivir Ther; 2015; 20(4):387-95. PubMed ID: 25624410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of hepatitis B virus reverse transcriptase region among untreated chronically infected patients in Ahvaz city (South-West of Iran).
    Hamidi-Fard M; Makvandi M; Samarbaf-Zadeh A; Hajiani E; Shayesteh A; Masjedizadeh A
    Indian J Med Microbiol; 2013; 31(4):360-5. PubMed ID: 24064642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.
    Yeh ML; Huang CF; Huang CI; Liu SF; Yang HL; Hsieh MY; Huang JF; Dai CY; Chuang WL; Yu ML
    PLoS One; 2014; 9(7):e101790. PubMed ID: 25000502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
    Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
    Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple-site analysis of HBV drug-resistant mutations in 340 patients with chronic hepatitis B].
    Xu DP; Liu Y; Cheng J; Li XD; Dai JZ; Li L; Liang ZL; Bai L; Zhong YW; Xu ZH; Ren XQ; Zhang LX
    Zhonghua Gan Zang Bing Za Zhi; 2008 Oct; 16(10):735-8. PubMed ID: 18983768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
    Tadokoro K; Suzuki F; Kobayashi M; Yamaguchi T; Nagano M; Egashira T; Kumada H
    J Virol Methods; 2011 Jan; 171(1):67-73. PubMed ID: 20950650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].
    Xu LJ; Pan C; Li QG; Chen RH; Zheng L; Zhang QY; Chen HC
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):180-3. PubMed ID: 20380793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.